New study maps the spread of brain changes in psychosis

Psychoses like schizophrenia cost billions of dollars annually and derail the lives of people struggling with the disease.

‘Budget Ozempic’: What to Know

With novel weight-loss drugs such as semaglutide (Wegovy) and tirzepatide (Zepbound) in short supply and selling for high prices, an age-old method for trying to

January 19, 2024

LIB details Ph3 PCSK9 inhibitor data; Eyenovia seeks ‘strategic alternatives’

Plus, news about Inozyme and Sensorion: LIB Therapeutics touts positive Phase 3 cholesterol results: The company’s third-generation PCSK9 inhibitor, lerodalcibep, achieved a 56% LDL-C reduction

April 9, 2024

Ro Unveils Vertically Integrated Platform for Seamless Patient Care

What You Should Know: – Ro, the leading direct-to-patient healthcare company, unveils ro.OS, a technology platform designed to transform the healthcare experience. – This comprehensive

May 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.